Evaluating joint stability in patients with collagen diseases and hypermobility
Evaluation of Functional Instability Using the "Delos Proprioceptive System" in Patients Suffering From Collagen Disease and Joint Hypermobility
This study is testing how well people with collagen diseases and joint hypermobility can keep their balance and stability during activities to see if postural corrections can help them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Istituto Ortopedico Rizzoli Academic / other |
| Locations | 1 site (Bologna) |
| Trial ID | NCT05871216 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients suffering from collagen diseases and joint hypermobility, specifically assessing their joint stability and balance. It utilizes clinical tests and the Delos Proprioceptive System to evaluate the effectiveness of postural corrections during dynamic activities. The study aims to identify deficiencies in balance that may affect daily and sporting activities, particularly in individuals diagnosed with Joint Hypermobility Syndrome. Diagnosis is based on the Beighton score and the presence of arthralgia in multiple joints.
Who should consider this trial
Good fit: Ideal candidates include individuals with moderate to severe joint hyperlaxity as indicated by the Beighton-Horan Joint Mobility Index.
Not a fit: Patients with obesity, significant comorbidities, or those without joint hyperlaxity will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for patients with joint hypermobility and related conditions.
How similar studies have performed: While there is ongoing research in this area, the specific approach of using the Delos Proprioceptive System for balance evaluation in this patient population is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with moderate (Beighton-Horan Joint Mobility Index score from 3 to 4) or severe (Beighton-Horan Joint Mobility Index score from 5 to 9) joints hyperlaxity at the clinical evaluation Exclusion Criteria: * Obesity (BMI \> 25) and weight \> 90 kg * Practice of competitive sport * Orthopedic (complex surgery of the spine and lower limbs), neurological (spasticity, stroke), and oncological comorbidities * Orthostatic / walking inability * Absence of joints hyperlaxity at the clinical evaluation (Beighton-Horan Joint Mobility Index score from 0 to 2)
Where this trial is running
Bologna
- IRCCS-Istituto Ortopedico Rizzoli — Bologna, Italy (Recruiting)
Study contacts
- Study coordinator: Maria Grazia Benedetti, MD
- Email: mariagrazia.benedetti@ior.it
- Phone: +39 051 6366236
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.